Fusion event
HBV-CLEC2L integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
139198706/139513960 (Hg38)
Nearest miRNA
hsa-mir-10399/Upstream/469803; hsa-mir-11400/Downstream/2960567;
Upstream sequence
ttcaggtgatccacccgcctcggcctcccaaagtgcagggattacagatgtcagccactgcgcctagccCAGCCTTCACCAACACATTTCTAACACCAGA
Downstream sequence
cccaggctggagtgcagtggtacaatcgcctcagcctcctgagtagctgggactacaggcacctgctaccacacctggctaatttttgtatttttggtag
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.